Thyroid Hormone Receptor (TR): a regulator in Liver Fibrogenesis

Conference paper


Manka, P, Coombes, JD, Bechmann, L, Swiderska-Syn, M, Reid, D, Claridge, LC, Younis, R, Mehta, K, Briones, MA, Kitamura, N, Mi, Z, Kuo, PC, Williams, R, Eksteen, B, Diehl, AM, Gerken, G, Canbay, A, Flamant, F, Gauthier, K and Syn, WK (2016). Thyroid Hormone Receptor (TR): a regulator in Liver Fibrogenesis. Fibrogenesis. New York 01 - 02 Jan 2016 doi:https://www.doi.org/10.1055/s-0036-1597375
AuthorsManka, P, Coombes, JD, Bechmann, L, Swiderska-Syn, M, Reid, D, Claridge, LC, Younis, R, Mehta, K, Briones, MA, Kitamura, N, Mi, Z, Kuo, PC, Williams, R, Eksteen, B, Diehl, AM, Gerken, G, Canbay, A, Flamant, F, Gauthier, K and Syn, WK
TypeConference paper
Abstract

Thyroid hormone (TH) signaling is critical for tissue-organ development, growth, differentiation and metabolism, and in the liver, the most widely expressed TH receptor is TRβ. In a recent study of patients with nonalcoholic steatohepatitis (NASH), progressive liver fibrosis was associated with disrupted TH signaling. In a separate study, low serum triiodothyronine (T3) was associated with advanced NASH-fibrosis. These findings suggest that TH signaling may be a novel regulator of adult liver fibrogenesis. Herein, we hypothesized that the TH-TR axis modulates HSC phenotype and perturbations in TH-TR axis occur during liver injury.

Methods: In vivo: Two murine liver injury models were used (6 weeks of methionine choline deficient (MCD) diet and 6 weeks carbon tetrachloride (CCL4) injection). Human tissues were obtained from explanted NASH and healthy donor livers. Liver fibrosis was assessed by Sirius Red (SR) staining, αSMA immunohistochemistry, and the hepatic hydroxyproline assay. Total liver expression of TRα and TRβ, αSMA and Collagen 1α1 mRNA were determined by qRT-PCR. In vitro: To determine whether TH modulates HSC activation, primary HSC and a HSC line were treated with transforming growth factor (TGF)-β (5 ng/ml), in the presence or absence of T3 (10 ng/ml). TRα knockdown in HSC was achieved using lentiviral-mediated shRNA (shTRα). Results were confirmed using TRα knock-out (TRαKO) mouse embryonic fibroblasts (MEF). HSC migration was assessed using the wound healing assay, western blot and qRT-PCR (αSMA, collagen 1α1, TRα and β). Hepatocytes were used as positive control for TRβ expression.

Results: Total liver TRα and TRβ mRNA were downregulated by 4-fold (p < 0.05) during liver fibrogenesis in mice and humans. In HSC, TRα is the predominant TR (4 fold higher than TRβ; p < 0.05). TGF-β stimulation of HSC repressed TRα and TRβ mRNA expression, but this effect was blunted by T3. shTRα-HSC exhibited greater activation at baseline, with increased fibrogenesis markers αSMA and collagen 1α1, and enhanced responses to TGF-β (increased p-Smad2/3). shTRα-HSC also had greater response in wound-healing assay (1.3-fold, p < 0.05), which was consistent with enriched contractility/migration pathways obtained from RNA sequencing analysis.

Conclusions: Liver expression of TRα and β is repressed during fibrogenesis following chronic liver injury. TRα is the predominant TR in HSC and perturbations in TH-TR levels regulate HSC phenotype via the TGF-β pathway. Future studies will be needed to determine if whether TH treatment could inhibit liver fibrosis progression.

Year2016
JournalZeitschrift für Gastroenterologie
Journal citation54 (12), pp. 1343-1404
ISSN0044-2771
Digital Object Identifier (DOI)doi:https://www.doi.org/10.1055/s-0036-1597375
Accepted author manuscript
License
CC BY 4.0
Publication dates
Print19 Dec 2016
Publication process dates
Deposited13 Feb 2019
Accepted09 Dec 2016
Permalink -

https://openresearch.lsbu.ac.uk/item/8710q

  • 2
    total views
  • 7
    total downloads
  • 1
    views this month
  • 3
    downloads this month

Related outputs

A Novel Human Neuronal Cell Model to Study Iron Accumulation in Parkinson’s Disease
Mehta, K, Ahmed, B and Farnaud, S (2019). A Novel Human Neuronal Cell Model to Study Iron Accumulation in Parkinson’s Disease. Journal of Alzheimers Disease & Parkinsonism. 9 (1), p. 461.
Measurement of 4-hydroxynonenal (4-HNE) protein adducts by ELISA
Mehta, K and Patel, V (2019). Measurement of 4-hydroxynonenal (4-HNE) protein adducts by ELISA. in: Hancock, John and Conway, Myra (ed.) Redox-Mediated Signal Transduction: Methods and Protocols, Methods in Molecular Biology, vol. 1990 Springer Science+Business Media, LLC, part of Springer Nature 2019.
Iron and liver fibrosis: mechanistic and clinical aspects
Mehta, K, Farnaud, S and Sharp, P A (2019). Iron and liver fibrosis: mechanistic and clinical aspects. World Journal of Gastroenterology. 25 (5), pp. 521-538.
Betaine, in context.
Mehta, K and Patel, V (2015). Betaine, in context. in: Preedy, V (ed.) Betaine: Chemistry, Analysis, Function and Effects The Royal Society of Chemistry.
Molecular and cellular insights into iron regulation
Mehta, K (2012). Molecular and cellular insights into iron regulation. PhD Thesis University of Westminster School of Life Sciences
Molecular Effects of Alcohol on Iron Metabolism
Mehta, K, Farnaud, S and Patel, VB (2016). Molecular Effects of Alcohol on Iron Metabolism. in: Molecular Aspects of Alcohol and Nutrition: A Volume in the Molecular Nutrition Series Academic Press. pp. 355-368
Oxidative Stress in Iron-toxicity of Liver
Mehta, K (2018). Oxidative Stress in Iron-toxicity of Liver. in: Patel, V (ed.) The Liver: Oxidative stress and dietary antioxidants Elsevier. pp. 43-54
Iron Enhances Hepatic Fibrogenesis and Activates Transforming Growth Factor-β Signaling in Murine Hepatic Stellate Cells.
Mehta, K, Coombes, JD, Briones-Orta, M, Manka, PP, Williams, R, Patel, VB and Syn, W-K (2018). Iron Enhances Hepatic Fibrogenesis and Activates Transforming Growth Factor-β Signaling in Murine Hepatic Stellate Cells. American Journal of the Medical Sciences. 355 (2), pp. 183-190.
Characterisation of hepcidin response to holotransferrin treatment in CHO TRVb-1 cells
Mehta, K, Greenwell, P, Renshaw, D, Busbridge, M, Garcia, M, Farnaud, S and Patel, VB (2015). Characterisation of hepcidin response to holotransferrin treatment in CHO TRVb-1 cells. Blood Cells, Molecules, and Diseases. 55 (2), pp. 110-118.
Characterization of hepcidin response to holotransferrin in novel recombinant TfR1 HepG2 cells
Mehta, K, Busbridge, M, Renshaw, D, Evans, RW, Farnaud, S and Patel, VB (2016). Characterization of hepcidin response to holotransferrin in novel recombinant TfR1 HepG2 cells. Blood Cells, Molecules, and Diseases. 61, pp. 37-45.
HFE mRNA expression is responsive to intracellular and extracellular iron loading: short communication
Mehta, K, Farnaud, S and Patel, VB (2017). HFE mRNA expression is responsive to intracellular and extracellular iron loading: short communication. Molecular Biology Reports. 44 (5), pp. 399-403.
Erratum to: HFE mRNA expression is responsive to intracellular and extracellular iron loading: short communication
Mehta, K, Farnaud, S and Patel, VB (2017). Erratum to: HFE mRNA expression is responsive to intracellular and extracellular iron loading: short communication. Molecular Biology Reports. 44 (5), pp. 405-405.
Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease
Riva, A, Patel, V, Kurioka, A, Jeffery, HC, Wright, G, Tarff, S, Shawcross, D, Ryan, JM, Evans, A, Azarian, S, Bajaj, JS, Fagan, A, Patel, V, Mehta, K, Lopez, C, Simonova, M, Katzarov, K, Hadzhiolova, T, Pavlova, S, Wendon, JA, Oo, YH, Klenerman, P, Williams, R and Chokshi, S (2017). Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease. Gut. 67 (5), pp. 918-930.
Case Studies: Effects of Beef, Whey and Carbohydrate Supplementation in Female Master Triathletes
Mehta, K, Seijo, M, Larumbe-Zabala, E, Ashrafi, N, Christides, T, Karsten, B, Nielsen, BV and Naclerio, F (2018). Case Studies: Effects of Beef, Whey and Carbohydrate Supplementation in Female Master Triathletes. Journal of Human Sport and Exercise. 14 (1), pp. 170-184.